Ross\Johnson & Associates’s Lockheed Martin LMT Stock Holding History

Ross\Johnson & Associates’s Portfolio LMT Stock Details LMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$484	–	291
2025 Q4	$484	Buy	+1	New	+$479	0.01%	160
2025 Q2	–	Sell	-7	Closed	-$3.13K	–	288
2025 Q1	$3.13K	Buy	+7	New	+$3.22K	0.05%	118

Other funds holding LMT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ross\Johnson & Associates's LMT Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of Lockheed Martin (LMT) in Q1 2026, closing a stake of 1 share — an estimated $484 sold.

Ross\Johnson & Associates first reported a position in LMT in Q1 2025 and held it in 2 quarters. The position peaked at $3.13K in Q1 2025. 2,909 funds tracked by Wall St. Rank hold LMT as of Q1 2026.

Ross\Johnson & Associates reported no remaining Lockheed Martin position as of Q1 2026 after selling out during the quarter.
Ross\Johnson & Associates sold 1 Lockheed Martin share in Q1 2026, an estimated $484.
Ross\Johnson & Associates first reported a position in Lockheed Martin in Q1 2025 and held it in 2 quarters.
Ross\Johnson & Associates's Lockheed Martin position peaked at $3.13K in Q1 2025.
2,909 funds tracked by Wall St. Rank held Lockheed Martin as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.